Apimeds Pharmaceuticals US, Inc.

US$2.71As of Sun 8 Nov 2026, 12:00 UTC
AMEX:APUSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$4.082M
ROIC (78.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.02
11.64%
82.26%
Hold 9|10|12|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.05
16.89%
11.82%
21.10%
20.98%
Revenue$M
0.443
0.453
0.451
0.458
(1.88%)
(2.52%)
(0.12%)
3.61%
Peers (US$4.082M)
Cap (US$)
PE
4.661M
—
Capital
TTM
5Y
10Y
Leveragex
0.280
(1.019)
(0.876)
EBIT/Intx
1.041
0.257
0.225
Own earn%
56.72
77.18
75.53
Sh yield%
43.18
40.29
40.79
Owners
Insiders/Inst%
11.54
71.18
Short interest%
0.96
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
3–9
$1 testx
0.2
Incr. ROIC%
1